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 Chapter 2 
 Essential Cases in the Development of Public 
Health Ethics 
 Lisa  M.  Lee ,  Kayte  Spector-Bagdady , and  Maneesha  Sakhuja 
2.1  Introduction 
 While “public health” has been defi ned as what society does to “assure the condi-
tions for people to be healthy” (Institute of Medicine  2003 , xi), public health  ethics 
is a “systematic process to clarify,  prioritize , and justify possible courses of public 
health action based on ethical  principles ,  values and beliefs of  stakeholders , and 
scientifi c and other  information ” ( Schools of Public Health Application Service 
 2013 ). Despite several important characteristics that distinguish public health from 
clinical medicine, at its start public health ethics borrowed heavily from  clinical 
ethics and  research ethics (see Chap.  1 ). In the 1980s, with the onset of the AIDS 
epidemic and unprecedented advances in biomedicine, the inability of clinical eth-
ics to accommodate the ethical challenges in public health from existing frame-
works led pioneering ethicists to reframe and adapt clinical ethics from an individual 
and  autonomy focused approach to one that better refl ected the tension between 
 individual rights and the health of a group or  population (Bayer et al.  1986 ; 
Beauchamp  1988 ; Kass  2001 ; Childress et al.  2002 ; Upshur  2002 ). Others called for 
public health ethics to emphasize relational ethics and  political philosophy (Jennings 
 2007 ). More recently, some authors have suggested outlining foundational  values 
from which operating principles for public health ethics can be articulated only after 
careful consideration of the goals and purpose of public health. This approach 
would require us to establish a clear defi nition  of the moral endeavor of public 
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health as a fi eld (Lee  2012 ) and construct an ethical framework stemming from the 
nature of it (Dawson  2011 ). 
 A versatile framework for public health ethics must accommodate public health 
in practice and  research . In public health practice, an  ethics framework must guide 
decisions about activities like  infectious disease control, primary  prevention , and 
 environmental health , as well as newer expectations of public health such as  chronic 
disease control and preparedness. In  public health research , biomedical and behav-
ioral  research ethics provide a great deal of guidance—but  research that focuses on 
population-based outcomes and community concerns reveals additional ethical 
considerations. 
 A fundamental tension in public health is one between individual- and population- 
based interests. Various  political traditions place different value on each, and these 
 values can fl uctuate within the same political structure over time. When authorities 
intervene to affect  population health , they must fi nd an equilibrium between indi-
vidual and population interests in all political contexts, whether authoritarian, 
socialist, or liberal individualist. To consider individual interests as well as popula-
tion interests, regardless of the philosophical tradition within which these interests 
are valued, is a challenge for a public health  ethics framework . The cases we present 
in this chapter illustrate how this equilibrium between individual and population 
interests has been established in the context of dynamic political and historical 
infl uences. 
 One way of approaching public health ethics deliberation is through the method 
of  casuistry , defi ned as “the interpretation of moral issues, using procedures of 
reasoning based on paradigms and analogies, leading to the formulation of expert 
opinion about the existence and stringency of particular moral  obligations , framed 
in terms of rules or maxims that are general but not universal or invariable, since 
they hold good with certainty only in the typical conditions of the agent and the 
circumstances of action” (Jonsen and Toulmin  1988 , 297). Consideration of case 
studies and the use of casuistic methods of resolution of morally similar cases 
through interpretation of ethical  principles have played important roles in the devel-
opment of public health ethics—particularly before public health ethics was viewed 
as distinct from  clinical ethics . Individual case studies enable discussions about 
which ethical  norms we should adopt for the practice of public health and how pub-
lic health  professionals should deliberate to resolve ethical problems in practice 
(Centers for Disease Control and Prevention [CDC]  2012 ) . In this chapter, we 
review several seminal cases that shaped the ethics of public health research and 
 practice over the past century to provide the foundation of current public health eth-
ics and lay the groundwork for a casebook to enable casuist analysis. 
 Our fi rst case example is  Jacobson v Massachusetts , set in the beginning of the 
twentieth century.  Jacobson  is  a foundational U.S. public health legal case that sup-
ports states’ rights to create and enforce  laws and  regulations that limit individual 
 autonomy to protect the public’s health and stop the spread of communicable dis-
ease. Our second case study, from the mid-1900s, looks at two ethically troubling 
 U.S. Public Health Service ( PHS ) protocols for studying sexually transmitted dis-
eases (STDs) in the U.S. state of  Alabama and  Guatemala . These experiments, like 
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most  research protocols, were not intended to benefi t the subjects; rather their intent 
was the broader benefi t of the public’s health. They show however, that researchers, 
despite the apparent motivation to advance public health, can breach public health 
 research ethics and  harm research subjects. The fi nal case, a contemporary example 
of the New York City  A1C Registry to monitor and address the  diabetes epidemic in 
the city, demonstrates how addressing the ethical dimensions of public health inter-
ventions can facilitate their implementation. This case moves our focus from public 
 health interventions targeting communicable diseases to those supporting second-
ary  prevention of  noncommunicable diseases . It focuses on the ethical dimensions 
that can arise when technological advances in communication might affect indi-
vidual  privacy . Unlike the consistent movement forward with which  casuistry has 
moved  clinical ethics , (Jonsen  1991 ), the outcomes in the cases we describe here 
shaped, and sometimes jolted, the nascent fi eld of public health ethics. 
 These three case studies, occurring within the same  political structure over the 
span of a century, illustrate the tension between individual  autonomy and protection 
of public health in very different ways. The fi rst case depicts a situation where the 
balance tipped in favor of protection of the public’s health in the context of  infec-
tious diseases . The second case demonstrates unconscionable exploitation of vul-
nerable  research subjects for the benefi t of other communities. Finally, the third case 
presents a situation in which solutions to public health problems based on techno-
logical advances and access to data can strike a balance with individual health  pri-
vacy concerns. Each case illustrates the quest for equilibrium between individual 
and  population interests . 
2.2  Case Study:  Jacobson v. Massachusetts 
 The earliest activities associated with modern public health are  sanitation and  infec-
tious disease control. From the fi rst  public health surveillance system in colonial 
America that required tavern keepers in Rhode Island to report contagious disease, 
to John Snow removing the Broad Street pump handle in London to end the 1854 
cholera epidemic, control of communicable diseases has been fi rmly in the jurisdic-
tion of public health (Thacker  2010 ). Discovery of the physiological mechanisms of 
 vaccines in the eighteenth century gave us new tools to control  infectious diseases 
but also raised critical questions about how to carry out—effectively and ethically—
 policies and plans that support individual and  community health . 
2.2.1  Background 
 By the turn of the twentieth century, public health campaigns—including improved 
hygiene, sanitation, and access to safer food and water—had already extended the 
average life expectancy in the  United States (CDC  1999 ). But  infectious diseases 
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were still the leading cause of mortality, with  tuberculosis , pneumonia, and  diar-
rheal disease accounting for 30 % of U.S. citizen deaths (Cohen  2000 ). Evolving 
support for the  government’s involvement in protecting public health led to the 
establishment of hygienic laboratories in 1887 (Kass  1986 ). These laboratories con-
tinue today to provide essential services such as diagnostics,  public health surveil-
lance ,  research , and  vaccine development. 
 Edward  Jenner , who discovered that a  vaccine for smallpox could be created 
using cowpox lesions, sent his vaccine from England to Benjamin  Waterhouse at 
Harvard University in 1800 (Riedel  2005 ). After successfully vaccinating the mem-
bers of his household, Waterhouse began selling the vaccine in Boston, Massachusetts 
(Kass  1986 ). Not all physicians vaccinated as meticulously as Waterhouse however, 
and in one unfortunate incident, adulterated smallpox vaccine caused an epidemic 
in the Boston area (Kass  1986 ). 
 As interest in and concern about the  vaccine grew, the Board of Health of Boston 
decided to perform one of the fi rst controlled  clinical trials in U.S. history, which 
eventually demonstrated  effectiveness of the vaccine (Kass  1986 ). A century later, 
Massachusetts had established  vaccination campaigns, but smallpox persisted: One 
hundred cases were reported in Massachusetts in 1900 with 2314 cases by 1902 
(Parmet et al.  2005 ). The Board of Health had originally promoted a  voluntary vac-
cination scheme until January 1902 when two  children , one in Boston, died of post-
vaccination complications within a month of each other (Willrich  2011 ). After 
voluntary efforts stalled, the Board ordered  mandatory vaccination in February, but 
did not enforce the order. After an outbreak sent another 50 adults and children to 
the hospital and caused seven deaths, the Board voted that the  regulations needed to 
be enforced (Willrich  2011 ). 
 Local public health offi cials employed creative ways to follow enforcement 
orders, “many of which were scientifi cally sound but not all of which were apt to 
inspire public  trust ” (Parmet et al.  2005 , 653). The Boston Herald, for example, 
reported in March 1902 that public health doctors and guards forcibly vaccinated 
“Italians, negroes and other employees” (Parmet et al.  2005 , 653). Despite the suc-
cess of the smallpox  vaccine in curtailing disease, anti-vaccinationists described 
compulsory  vaccination as “the greatest crime of the age” and as “more important 
than the slavery question, because it is debilitating the whole human race” 
(Washington Post  1905 ; Gostin  2008 , 122). Pro-vaccinationists were as polarizing, 
describing the debate as “a  confl ict between intelligence and ignorance, civilization 
and barbarism” (New York Times  1885 ; Gostin  2008 , 122). 
2.2.2  Case Description 
 It was in this context that the U.S. Supreme Court heard  Jacobson v. Massachusetts , 
which despite, and perhaps because of, the vastly different ways it has been inter-
preted and applied since then, is arguably the most important legal public health 
case ever decided in the  United States (Gostin  2005 ). Under the doctrine of “police 
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power,” it had already been established in the late 1800s that states had the authority 
to enforce “sanitary  laws , laws for the protection of life,  liberty , health or property 
within its limits [and] laws to prevent persons and animals suffering under conta-
gious or  infectious diseases …” within their own boundaries (R. R. Co. v. Husen 
 1877 , 465, 472). In 1885, the Supreme Court confi rmed that this included ensuring 
conditions essential to the “ safety , health, peace, good order and morals of the com-
munity” as “even  liberty itself… is only  freedom from restraint under conditions 
essential to the equal enjoyment of the same right by others” (Crowley v. Christensen 
 1890 , 86, 89). 
 In 1902, in response to the increase in smallpox cases discussed above, the 
Cambridge,  Massachusetts Board of Health issued an order, which became  law , 
requiring citizens be vaccinated against smallpox or pay a $5 fi ne (the equivalent of 
about $135 in 2015) (Massachusetts Revised Laws  1902 ; Commonwealth v. 
Henning Jacobson  1903 ; Mariner et al.  2005 ). Henning  Jacobson , a Cambridge 
minister, refused both the  vaccination  and to pay the fi ne. He argued he had previ-
ously received the smallpox vaccination in  Sweden as a child and had experienced 
“great and extreme suffering, for a long period” as a result and that one of his sons 
had experienced  adverse events from vaccination as well (Commonwealth v. 
Henning Jacobson  1903 , 246).  Jacobson argued that the  law was thus “hostile to the 
inherent right of every freeman to care for his own body and health in such way as 
to him seems best ....” (Jacobson v. Massachusetts  1905 , 26) . The case went to trial. 
 At trial,  Jacobson argued that his history of adverse reaction to the smallpox  vac-
cine should grant him an exception from the  law . However, the law did not actually 
provide for such exceptions for adults (as it did for  children ). Jacobson was found 
guilty of “the crime of refusing  vaccination ” (Willrich  2011 , 285). He appealed to 
the superior court, where the judge again ruled that Jacobson’s medical history was 
“immaterial” to his legal violation. The judge also refused Jacobson’s plea to tell the 
jury that the law was a violation of the constitutions of Massachusetts and the  United 
States because it offered no such exception. The court again found  Jacobson guilty 
(Willrich  2011 ) . 
 Jacobson fared no better in the Massachusetts Supreme Court. It too rejected 
Jacobson’s evidence of his prior adverse experience with the  vaccination as well as 
his son’s as “matters depending upon his personal opinion, which could not be taken 
as correct, or given effect, merely because he made it a ground of refusal to comply 
with the requirement” (Commonwealth v. Henning Jacobson  1903 , 246). Moreover, 
it pointed out that even if Jacobson  could prove that he would suffer adverse effects 
from the  vaccine , the statute did not offer an exception for such a case. In response 
to Jacobson’s argument that this defi ciency rendered the statute unconstitutional, the 
court responded that the “theoretical possibility of an injury in an individual case as 
a result of its  enforcement does not show that as a whole it is unreasonable. The 
application of a good  law to an exceptional case may work hardship” (Commonwealth 
v. Henning Jacobson  1903 , 247). However, the Massachusetts court held that if citi-
zens refused to be vaccinated it was not within the  power of public health authorities 
to vaccinate them by force (as the Boston Herald had reported occurring) 
(Commonwealth v. Henning Jacobson  1903 ; Parmet et al.  2005 ) . 
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 When the  Jacobson  case fi nally made its way to the U.S. Supreme Court, the 
Court found that the  vaccination statute was generally a reasonable protection of the 
public health while maintaining  individual liberty . The Supreme Court did conclude 
that to subject someone to vaccination who was unfi t because of a health condition 
“would be cruel and inhuman in the last degree;” it stipulated that “we are not 
inclined to hold that the statute establishes the absolute rule that an adult must be 
vaccinated if it be apparent or can be shown with reasonable certainty that he is not 
at the time a fi t subject of vaccination or that vaccination, by reason of his then 
condition, would seriously impair his health or probably cause his death” (Jacobson 
v. Massachusetts  1905 , 38–39) . However, the Court found that  Jacobson was “in 
perfect health and a fi t subject of vaccination” and that he simply “refused to obey 
the statute and the  regulation adopted in execution of its provisions for the protec-
tion of the public health and the public  safety , confessedly endangered by the pres-
ence of a dangerous disease” (Jacobson v. Massachusetts  1905 , 39) . The Court 
ordered Jacobson to submit to vaccination or pay the fi ne (Jacobson v. Massachusetts 
 1905 ). Three years after his legal fi ght began,  Jacobson paid the $5 penalty (Willrich 
 2011 ). 
2.2.3  Discussion 
 Legal cases since 1890 had allowed states to require citizens be vaccinated, but 
around the turn of the century, limits to that right began appearing that included a 
“present danger”  standard requiring a real and immediate threat and adherence to 
the harm avoidance  principle protecting citizens from undue burden as much as pos-
sible (Willrich  2011 ).  Jacobson has endured as a fundamental philosophical foun-
dation of the reconciliation of individual interests with those of the public’s health 
in a  political system emphasizing liberal  individualism . 
 Despite the limitations of the facts in  Jacobson , it has been interpreted in many 
ways to support numerous public health activities over the past century. Notably, the 
Supreme Court did not require that otherwise healthy citizens submit to  vaccination , 
only that it was constitutional to require citizens to be vaccinated  or pay a fi ne. Also, 
while the Court found that a lack of a health exception to the vaccination mandate 
would be unconstitutional, it did not grant Jacobson this exception for himself. 
 However, as with so many examples in the lexicon of medical ethics, one of the 
most important practical effects of historical cases is how they have been interpreted 
and applied to future circumstances. Part of  Jacobson ’ s legacy has been the Court’s 
“community oriented philosophy” based in social-contract (or compact) theory 
(Gostin  2005 , 578): “a fundamental  principle of the social compact [is] that the 
whole people covenants with each citizen, and each citizen with the whole people, 
that all shall be governed by certain  laws for ‘the common good ….’” (Jacobson v. 
Massachusetts  1905 , 26) . While the Court recognized  individual liberty interests 
protected by the Constitution, it found that these interests did not impart an absolute 
right of  freedom from restraint because “on any other basis organized society could 
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not exist with  safety to its members” (Jacobson v. Massachusetts  1905 , 26) . It noted 
that no citizen could enjoy full  liberty in a society that recognized “the right of each 
individual person to use his own [liberty] … regardless of the injury that may be 
done to others” (Jacobson v. Massachusetts  1905 , 26). 
 The Court also found that reasonable  regulations to protect the public health and 
 safety were among these constitutional limits on  liberty (Jacobson v. Massachusetts 
 1905 ). Despite the fact that  Jacobson found  mandatory vaccination distressing and 
objectionable, it was the responsibility of the city board of health to “not permit the 
interests of the many to be subordinated to the wishes or convenience of the few” 
(Jacobson v. Massachusetts  1905 , 29) . As discussed above, the Court found that 
exceptions were needed for citizens with established concerns for their health—but 
did not apply this exception in Jacobson’s case. 
 The social contract implied in this case also needed to be reconciled with limits 
on  government and constitutional protections of  individual liberty . While the Court 
had already established a  standard of fair application of public  health interventions 
(e.g., not targeting a specifi c race-based group) (Jew Ho v. Williamson  1900 ; Gostin 
 2008 ),  Jacobson  built on several cases to further explain  standards of constitutional 
protections (i.e., there must be a public health threat to the community, and the state 
or board of health must design the public  health intervention to combat that threat). 
The Court found that the intervention must be proportionately tailored to that threat 
creating a “reasonable balance … between the public good and the degree of per-
sonal invasion ” and should not  harm citizens in and of itself (Gostin  2008 , 
126–127). 
 While it is hard to reconcile some of the facts of  Jacobson with its lofty consti-
tutional deliberation, it is the Court’s desire to reconcile individual interests with 
those of the public health in a society that  values liberal  individualism that has 
become its enduring legacy. Many court decisions following  Jacobson reaffi rmed 
states’ use of police  power for the public health (Gostin  2005 ), and in 1922 the 
Supreme Court agreed that states could require vaccinations for  children who attend 
 school (Zucht v. King  1922 ).  Jacobson was an important step in the lengthy public 
health battle against smallpox, culminating in its eradication in 1977 (Cohen  2000 ). 
 The legal and ethical boundaries between the individual and public health remain 
mobile in public health  law and  policy despite the  Jacobson decision. 
Notwithstanding its rejection of forced vaccination, coercion—as opposed to the 
modern emphasis on education—continued as a public health tactic, employed fre-
quently and often directed toward vulnerable citizens (e.g., quarantined sex work-
ers during World War I) (Colgrove and Bayer  2005 ). And despite the  liberty 
protections it carved out, the Court itself struggled with upholding both  individual 
rights and constitutional liberties. In 1927, citing  Jacobson , the Court upheld a 
forced-sterilization  law in Virginia of “mental defectives.” The  Buck v. Bell deci-
sion reasoned that “[i]t is better for all the world, if instead of waiting to execute 
degenerate offspring for crime, or to let them starve for their imbecility, society can 
prevent those who are manifestly unfi t from continuing their kind. The  principle 
that sustains compulsory vaccination is broad enough to cover cutting the fallopian 
tubes” (Buck v. Bell  1927 , 207). 
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 In more communitarian-leaning societies,  Jacobson ’ s value serves less as a map 
for navigating public good in an individualist context, and more as an illustration of 
how individual and community interests can be balanced within the  political and 
social structure. Even within the  United States , however,  Jacobson has been inter-
preted over the decades to be a foundation for diverse legal opinions supporting 
remarkable expansions of federal  power —including warrantless entry into homes in 
time-sensitive circumstances of compelling need and a defense of the federal  govern-
ment’s right to detain U.S. citizens without due process as “enemy combatants” (in a 
dissenting opinion) (Willrich  2011 ). Many of these cases, and certainly  Buck v. Bell  
serve as a stark reminder that federal  powers ostensibly in the public interest cannot 
be used solely to maximize perceived public benefi t—they must be tempered by  jus-
tice and  fairness to both communities and individuals (Lombardo  2008 ). But as the 
legal community continued to struggle with what the implications and contours of 
what  Jacobson should be in the  United States , offi cials continued to press on in what 
was then an unregulated fi eld—that of  public health research . 
2.3  Case Study:  U.S. Public Health Service Research 
on Sexually Transmitted Disease:  Alabama 
and  Guatemala 
 Since the 1940s, contemporary  research ethics has developed rapidly through a 
desire to protect human participants in research. Internationally, the Nuremberg 
Trials for Nazi war criminals, including the trial of Nazi physicians who conducted 
torturous medical experiments on subjects, resulted in the  Nuremberg Code ( 1947 ), 
a compilation of  guidelines for conducting research with human participants. In 
1964, the World Medical Association’s (WMA)  Declaration of Helsinki further 
refi ned ethical guidance for research with humans, and in particular the  participa-
tion of vulnerable  populations (WMA  1964 ). 
 The next case study focuses on two separate mid-century U.S. PHS experiments 
on sexually transmitted diseases in the U.S. state of Alabama and  Guatemala . While 
one of the ten  essential public health services is to “conduct research to attain new 
insights and innovative solutions to health problems” (CDC  2013b ; Harrell et al. 
 1994 , 29), these experiments demonstrate how an imbalance of population and indi-
vidual interests—coupled with disregard for respect for persons—can lead to tragic 
results. 
2.3.1  Background 
 In the early 1900s, STDs—and  syphilis in particular—were major concerns for 
public health. Conservative estimates suggested that syphilis affected 10–15 % of 
the U.S.  population (Jabbour  2000 ) with symptoms ranging from sores to paralysis, 
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blindness, and  death  (CDC  2013a ). One leading expert at the time described syphi-
lis as a plague “which, in these times of public enlightenment, is still shrouded in 
obscurity, entrenched behind a barrier of silence, and armed, by our own ignorance 
and false shame, with a thousand times its actual  power to destroy…” (Stokes 
 1920 , 7). In 1905, German scientists isolated the microbe that caused syphilis, and 
in 1910 other scientists proposed salvarsan (a preparation of arsenic) as the cure 
(Jones  1993 ). Salvarsan  treatment involved a painful set of injections over a long 
period and ultimately turned out to be highly toxic (Jones  1993 ). 
 In 1912, the U.S.  government established PHS to join other federal public health 
efforts to improve administration and distribution of public health aid to the states, 
to oversee interstate  infectious diseases and  sanitation , and to conduct  public health 
research (Jones  1993 ). In 1918, PHS established a  Division of Venereal Disease to 
organize and support state prophylactic and  treatment work (Jones  1993 ). World 
War I had highlighted the harmful effect of STDs on the U.S. armed forces, but after 
interest in the disease from a wartime perspective abated, public health workers 
focused on  syphilis as a poverty-linked disease—and a disease that reportedly 
affected  African Americans in particular. Some physicians even argued that syphilis 
was a “quintessential black disease” and African Americans a “notoriously syphilis-
soaked race” (Jones  1993 , 24, 27). 
 Funding for and interest in preventing and treating STDs waned during peace-
time, though they remained a public health problem. With World War II on the 
horizon, the director of the PHS Venereal Disease Research  Laboratory argued that 
“[t]he  prevention of the primary invasion of the male by the  syphilis spirochete, as 
a means of minimizing the loss of  effectiveness which is incident to established 
disease, still constitutes one of the most pressing problems of military medicine” 
(Mahoney  1936 , 78–79). When the  United States became involved in World War II, 
public health offi cials once again became concerned about STD rates in American 
troops and predicted “approximately 350,000 fresh infections with gonorrhea [in 
the armed forces], [which] will account for 7,000,000 lost man days per year, the 
equivalent of putting out of action for a full year the entire strength of two full 
armored divisions or of ten aircraft carriers” (Presidential Commission for the 
Study of Bioethical Issues [PCSBI]  2011 , 12). The  cost of treating the anticipated 
infections was $34 million (about $465 million in 2015, adjusted for infl ation) 
(PCSBI  2011 , 12) . 
2.3.2  Case Description 
 In search of a more effective  treatment for syphilis, U.S. PHS researchers in the 
1930s had turned to  African-American communities for  public health research in 
part because of the perception of high rates of infection, as discussed above. PHS 
surveyed six southern counties and found the highest syphilis rates among black 
men in Macon County, Alabama, where the city of Tuskegee serves as the county 
seat. Created in part by a confl uence of economic, social, and clinical 
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factors—including the Great Depression, lack of public and private funds for con-
tinuation of development projects, pervasive  racism in American medicine, and 
failed attempts in the pre-penicillin era to treat  syphilis with heavy metals—public 
health researchers decided to conduct a study to observe the “natural progression” 
of untreated syphilis (Brandt  1978 ; U.S. Department of Health, Education, and 
Welfare [HEW]  1973 ). 
 The Tuskegee syphilis study or, more accurately, the  U.S. Public Health Service 
 Study of Untreated Syphilis in the Male Negro ,  Macon County ,  Alabama , was an 
observational study of 399 men with syphilis, and 201 men without, conducted from 
1932 through 1972. After 40 years, it fi nally ended when a PHS STD investigator, 
Peter Buxton, went to the press with allegations of gross ethical violations, includ-
ing a lack of  informed consent for  participation , deception, withholding  treatment , 
as well as racism and lack of scientifi c soundness (Jones  1993 ; Brandt  1978 ). 
 During this study,  public health researchers posed as physicians and told the 
men, who were already infected with  syphilis , that they were going to  treat them for 
“bad blood” (which, in common vernacular referred to a range of chronic conditions 
of unknown origin that could have included anything from syphilis to anemia). In 
reality, the researchers were not treating the subjects for any of these diseases. 
While during the salvarsan-era, nontreatment would not necessarily have made a 
large difference  clinically , once the Venereal Disease Research Laboratory estab-
lished that penicillin was a safe, effective, and inexpensive cure for syphilis in 1943, 
the profound clinical detriment of being a study participant became clear. After 
1943, the researchers actively kept subjects from receiving penicillin for other ail-
ments so as not to interfere with their ability to analyze the primary outcome of 
interest, which was the natural progression of untreated  syphilis (CDC  2013c ). 
 Throughout the study, the public health researchers practiced active deceit result-
ing in 399 infected men being kept from penicillin  treatment until their death or 
1972 when the study was stopped. The Assistant Secretary for Health and Scientifi c 
Affairs, under the then U.S. Department of Health, Education, and Welfare, char-
tered an advisory panel to investigate the circumstances surrounding the study. The 
panel later issued the Final Report of the Tuskegee Study Ad Hoc Advisory Panel in 
April 1973 (HEW  1973 ). 
 Meanwhile, the experience of soldiers during World War II had confi rmed the 
need for improved diagnosis and  treatment of STDs. After the war, these efforts 
were revitalized by animal studies that demonstrated the  effectiveness of a new 
post-exposure prophylaxis called “orvus-mapharsen.” PHS was interested in 
whether this solution would be effective in humans, and it was believed that 
 establishing effi cacy in humans required controlled intentional exposure in 
humans—preferably via the “natural method” of sexual intercourse. Because, in 
part,  commercial sex work was legal in the prison in Guatemala City, Guatemala, 
the researchers planned to conduct prophylaxis experiments there. The plan was to 
intentionally expose  prisoners to STDs through sexual intercourse with  commercial 
sex workers carrying  infection (PCSBI  2011 ). 
 As a result, from 1946 through 1948, the U.S.  government funded, via a federal 
grant from the National Institutes of Health and approved by the highest echelons of 
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PHS (including Surgeon General Thomas Parran) , STD, serological, and inocula-
tion experiments in Guatemala (Spector-Bagdady and Lombardo  2013 ). The 
researchers, led on the ground by a senior surgeon in the PHS, John C.  Cutler , soon 
discovered that they could not reliably infect prison subjects with STDs through 
sexual intercourse with  commercial sex workers ; the researchers were thus unable 
to compare the  effectiveness of the prophylaxis regimen they were testing. In an 
effort to increase infection rates, researchers expanded to other vulnerable  popula-
tions , such as soldiers and psychiatric patients, and engaged in more invasive meth-
ods of intentional exposure, such as abrasion of genitals and manually applying 
syphilitic emulsion—despite objections of their PHS supervisors that the latter 
methods of inoculation were scientifi cally  unsound (PCSBI  2011 ). 
 By the end of these experiments, considered by some at the time to be “ethically 
impossible” in design (Kaempffert  1947 ), public health researchers intentionally 
exposed approximately 1300 Guatemalan  prisoners , soldiers,  commercial sex work-
ers , and psychiatric patients to  syphilis , gonorrhea, and/or chancroid without 
 informed consent . The researchers documented some form of  treatment for only 
half of the subjects they exposed to infection (PCSBI  2011 ). 
 The Guatemala STD  experiments ended in 1948 when the researchers decided 
not to apply for a continuation of funding due to concerns about reporting project 
activities to the approving study section and the new surgeon general in the  United 
States (PCSBI  2011 ) . The Guatemala STD experiments remained undiscovered for 
nearly 65 years until Cutler’s  papers , uncovered in 2003, were brought to the atten-
tion of the U.S.  government and presented at a  professional meeting in 2010 (PCSBI 
 2011 ; Reverby  2011 ). Upon learning of the experiments, President Barack Obama 
requested that his Presidential Commission for the Study of Bioethical  Issues 
(Bioethics Commission) conduct a historical review and ethical analysis of the stud-
ies in Guatemala. The Bioethics  Commission concluded its analyses and reported 
its results to President Obama in September 2011 (PCSBI  2011 ). 
2.3.3  Discussion 
 The U.S. PHS Study of Untreated  Syphilis in the Negro Male unmasked a range of 
important ethical issues that fi t into three fi elds of  bioethics we now call  profes-
sional ethics, public health ethics, and  research ethics . Through the lens of profes-
sional ethics, the untreated syphilis study calls into question what it means to be an 
ethical scientist, an ethical physician, and an ethical  government steward of public 
 trust . Through the public health ethics lens, it raises issues of imposing the  risk of 
 harm to individuals to benefi t the community, appropriate engagement with the 
affected community, and  justice and  fairness . 
 Far and away, however, the untreated  syphilis study in Tuskegee had the most 
substantial impact on  research ethics . It was not the fi rst study to egregiously 
 disrespect  personal autonomy and grossly exploit vulnerable  populations . Indeed, 
by 1966, Henry Beecher had outlined 22 such studies in clinical research, some 
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involving  children , mentally and physically compromised patients, and incarcerated 
individuals (Beecher  1966 ). Nor was it the fi rst instance of African Americans being 
mistreated by the medical establishment (Gamble  1997 ), but it was the fi rst unethi-
cal study of this magnitude scandalously exposed by the mainstream media involv-
ing and funded by the U.S. federal government. While the original intent of the 
untreated  syphilis study in Tuskegee was to contribute to the greater and seemingly 
more urgent social good, it has been remembered for withholding  treatment from a 
socially and politically vulnerable  group by actively deceiving them. 
 Comprehensive scholarship has examined the legacy of the untreated syphilis 
study. Its impact is as deep as it is broad in the  bioethics community and the social 
culture of the  United States . This case study examines only the  policy outcomes that 
resulted from the  ethical review and analysis of the untreated  syphilis study, which 
is but a small slice of its legacy, yet one that has profoundly shaped the way clinical 
and  public health research is conducted in the United States. 
 The Tuskegee Study Ad Hoc Advisory Panel (Advisory Panel) submitted its fi nal 
report to then Assistant Secretary for Health, Charles C. Edwards, in April 1973 
(HEW  1973 ). The Advisory Panel found that the study was ethically unjustifi ed in 
1932 due to the lack of evidence that any  consent was obtained from participants, 
breaking “… one fundamental ethical rule…that a person should not be subjected to 
avoidable  risk of death or physical  harm unless he freely and intelligently consents” 
(HEW  1973 , 7). Also, the lack of a study protocol or plan left the study’s scientifi c 
soundness highly suspect, especially in light of the “disproportionately meager” 
scientifi c data it produced (HEW  1973 , 8). 
 Besides the lack of  informed consent , other important ethical violations noted by 
the Advisory Panel included researchers lying and withholding penicillin even after 
it was established to be effective as a  treatment for syphilis. The insults to basic 
dignity and  respect for  persons forced on the men in the study convinced the 
Advisory Panel to recommend a permanent body to regulate all federally supported 
 research involving human participants. This permanent body was to formulate  poli-
cies for establishing institutional review boards (IRBs) , compensating research par-
ticipants who suffer research-related injury, and reviewing protocols at local 
institutions before beginning  research studies . It also called for creating local sub-
ject advisory groups to monitor  consent procedures (HEW  1973 ). While the 
U.S. Department of Health, Education, and Welfare (now the  U.S. Department of 
Health and Human Services ) had  guidelines for  research grants and contracts, the 
Advisory Panel recommended “… that serious consideration should be given to 
developing, through Congressional action, rules and procedures which apply to the 
entire human research enterprise without reference to the source of funding” (HEW 
 1973 , 37). 
 The Advisory Panel report paved the way for creation of the fi rst congressionally 
formed national  bioethics committee : the  National Commission for the Protection of 
Human Subjects of Biomedical and Behavioral Research (National Commission) . 
As a direct consequence of the ethical investigation into the untreated  syphilis study, 
and acknowledgment that this was not an isolated incident, the National Commission 
began work in 1974 developing national  guidelines for  research involving human 
participants. 
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 The National Commission’s most cited work, the  Belmont Report , outlined three 
ethical  principles for research still in use today:  respect for persons ,  benefi cence , 
and  justice (National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research  1979 ) . It also provided guidance on  informed 
consent , special rules for  vulnerable populations , and requirements for review of 
protocols by  IRBs . These recommendations, later codifi ed into federal  regulations 
that govern federally funded research with human participants, continue to infl u-
ence human research today—helping ensure the respectful and ethical  treatment of 
participants in biomedical and  public health research (U.S. Department of Health 
and Human Services  2009 ). 
 A more subtle, but enduring impact of the National Commission’s efforts spe-
cifi c to public health  research was its focus on engaging the community in which 
research is to be conducted. Although only anecdotally reported, a lack of  trust in 
 government , health care, and research is widely believed to be a lasting consequence 
of the untreated  syphilis study (Gamble  1993 ; Swanson and Ward  1995 ). Empirical 
data suggest, however, that the untreated syphilis study itself did not deter  participa-
tion (Katz et al.  2008 ), but rather a lack of trust stemming from a larger social legacy 
of  racism and fears of exploitation originating in the era of slavery in the  United 
States (Gamble  1993 ). In recent times, these fears resurfaced at the onset of the 
AIDS epidemic in the 1980s in the form of suspicion of intentional infection and 
genocide (Jones  1993 ). This mistrust resulted in the distribution of misinformation 
and diffi culties in delivering education and care for those at high  risk for  HIV 
(Thomas and Quinn  1991 ). Since then, methods and best practices for community 
engagement have been developed and published both in the United States (Barnett 
 2012 ; U.S. Department of Health and Human Services  2011 )  and  internationally 
(World Health Organization [WHO]  2012 ; UNAIDS  2011 ). 
 When analyzing the effect of the Guatemala STD  experiments on public health 
ethics, it is important to note that while the experiments took place in the 1940s, 
they were critically investigated only recently—65 years after their occurrence. 
Despite the stark contrast of today’s regulated research context with  research con-
ducted in the 1940s, scholars continue to examine the original research documents, 
and our ability to learn from past errors continues. That the U.S. government, at 
least, had learned lessons from the Tuskegee study is evident by the swiftness of its 
response to the discovery of the Guatemala STD experiments. While it took 25 years 
for a U.S. president to apologize to the Tuskegee  syphilis study participants, fami-
lies, and community (The White House  1997 ), President Barack Obama called 
President Alvaro  Colom of Guatemala to apologize for the STD research immedi-
ately following the announcement of its discovery to the public in 2010. 
 The PHS  research studies in Tuskegee and Guatemala demonstrate the serious 
consequences that can result when the relative interests of the individual and the 
 population are inappropriately reconciled. Indeed, these abuses of individual 
research subjects have created an enduring legacy of cautionary tales that, together 
with an orientation toward liberal  individualism , have provided a lasting and 
powerful check on public health authority in the  United States . Major  policy 
changes were put into practice after the discovery of the syphilis studies in  Alabama . 
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These policies were intended to protect research participants from being treated as 
mere means to an end, to bring back into equilibrium the individual and population 
interests that public health must reconcile. Still, public  health interventions continue 
to face resistance to actions perceived to limit individual choice—making substan-
tive engagement of the relevant community even more critical for turn-of-the-cen-
tury public health campaigns. The case that follows describing the New York City 
 A1C Registry highlights how, even after all of the regulatory and ethical work 
accomplished over the past four decades, innovative approaches to public health 
advances interpreted to curtail some  individual liberty can still inspire debate about 
the optimal role of  government in promoting public health. 
2.4  Case Study:  The New York City  A1C Registry 
 Public health increasingly has focused on  secondary prevention , or the prevention 
of disability from disease. As the burden of disease in the  United States has shifted 
from communicable diseases like smallpox and STDs to  noncommunicable 
diseases , public health  professionals face new ethical challenges related to 
monitoring chronic conditions and inspiring individuals to improve their health. 
The following case illustrates how new technologies affect public  health 
interventions and can limit the  precedent set by  Jacobson  when health  risks are 
neither communicable nor imminent. Such cases call for a recalibration of  population 
and individual interests when considering dramatically different health and social 
settings. 
2.4.1  Background 
 Although  infectious diseases accounted for more than 80 % of deaths in the  United 
States in the 1900s (Steinbrook  2006 ), in 2011, WHO estimated that  noncommuni-
cable diseases were responsible for 66 % of deaths worldwide (WHO  2013 ). These 
changes in the causes of morbidity and mortality are typical of an “epidemiologic 
transition,” a  population health phenomenon that occurs when populations carry out 
public health measures such as  sanitation and immunization, which decrease death 
rates from  infectious diseases , increase life expectancy, and simultaneously begin to 
increase  risk for noncommunicable conditions (McKeown  2009 ). 
 Of  noncommunicable disease deaths worldwide in 2008, deaths from  diabetes 
alone accounted for 1.3 million (WHO  2011 ). In the  United States , 8.3 % of the 
population (about 25.8 million people) had diabetes in 2011 (CDC  2011 ) . Because 
of the signifi cant impact that  noncommunicable diseases , such as diabetes, have on 
health systems, WHO has promoted  lifestyle modifi cations and other public  health 
interventions (WHO  2011 ). 
 Several interventions, such as providing advice about physical activity and a 
healthy diet to people with impaired glucose tolerance, have lowered rates of  diabe-
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tes (Dornhorst and Merrin  1994 ; Ramachandran et al.  2006 ).  Research also has 
shown that controlling blood sugar levels (measured by A1C levels), blood pres-
sure, and LDL cholesterol can reduce the  risk of long-term complications and death 
among people with diabetes (Chamany et al.  2009 ). Some evidence suggests 
improvements from educating patients in diabetes management, but more evidence 
is needed (Chamany et al.  2009 ). 
 Although there are effective ways of controlling risk factors for complications 
once diabetes is diagnosed, management of these  risk factors across the  United 
States has been deemed inadequate (Chamany et al.  2009 ). In New York City the 
percentage of adults who reported having  diabetes more than doubled from 3.7 % in 
1994 to 9.2 % in 2004 (Chamany et al.  2009 ). A 2005 report of the  New York City 
Department of Health and Mental Hygiene (NCY DOHMH) showed that diabetes 
prevalence was higher among non-white residents (NCY DOHMH  2007 ; NCY 
DOHMH  2006a ). In 2004, NCY DOHMH found that diabetes was the fourth lead-
ing cause of death in the city’s population (NCY DOHMH  2004 ), and a survey of 
New York City adults in 2004 showed that fewer than 10 % of those with diabetes 
were able to manage blood sugar, blood pressure, and cholesterol satisfactorily 
according to city public health  standards (Chamany et al.  2009 ). In New York City, 
37 % of  diabetes patients on state and federally funded  Medicaid had an A1C level 
(refl ecting average blood sugar) greater than 9 %—which suggests poor glycemic 
control (Barnes et al.  2007 ). WHO has found that  policies that promote manage-
ment of these  risk factors have potential to reduce spending for individuals and the 
public (WHO  2011 ). 
2.4.2  Case Description 
 In December 2005, the NCY DOHMH submitted a proposal to the New York City 
Board of Health that would require laboratories with electronic reporting capabili-
ties to submit A1C test results for New York City residents to the NCY DOHMH 
(NCY DOHMH  2005a ). After a period for public comment, the New York City 
Board of Health approved this proposal, creating the fi rst U.S. program requiring 
public health reporting of A1C results. Supported by evidence from the success of 
other disease control programs (such as programs targeting lead poisoning and 
 tuberculosis ), this program established a  public health surveillance system to track 
 diabetes in the  population and to support those who could benefi t from diabetes 
control (Chamany et al.  2009 ). 
 The mandate required applicable laboratories to submit A1C test results to the 
NCY DOHMH within 24 h of completion. Data to be reported included date of 
the test; name of the testing facility; name and address of the ordering facility or 
provider; and name, address, and date of birth of the individual tested (Chamany 
et al.  2009 ). The NCY DOHMH proposed to use the reported A1C results to gener-
ate a registry to monitor glycemic control in the New York City  population and to 
provide mechanisms to support patients and physicians in controlling diabetes 
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(NCY DOHMH  2005a ). The data in the registry were analyzed by various factors 
including age, location, and type of health care facility to determine distinctions in 
testing patterns, health care usage, and glycemic control. However, race and ethnic-
ity data were not reported and therefore not included in the longitudinal analysis 
(Chamany et al.  2009 ). 
 After the A1C test results reached the NCY DOHMH, if the average blood sugar 
level exceeded a predetermined threshold, the patient and provider were notifi ed. 
Providers were mailed a roster of their patients ordered from highest to lowest A1C 
level, listing the patients’ two most recent test results calling special attention to 
A1C levels greater than 9 % (NCY DOHMH  2006b ). Patients at least 18 years of 
age with an A1C level greater than 9 % or who were overdue for testing also received 
a letter informing them of their test results, advising them on how to control their 
A1C level, and specifi cally recommending a follow-up appointment with their pro-
vider. The letter was printed in English and Spanish (NCY DOHMH  2005a ). 
 The goals of the provider and patient notifi cation program were to increase pro-
viders’ knowledge about glycemic control in their patient  population , facilitate pro-
viders in assisting and guiding patients at high  risk for complications, and inform 
and aid patients at high risk for devastating sequelae (NCY DOHMH  2012 ). While 
patients had the option to opt- out of the provider and patient notifi cation program, 
laboratories were still required to report their data to the registry (NCY DOHMH 
 2005b ). Reported data were held confi dentially and were unavailable to insurers, 
licensure organization, or employers (NCY DOHMH  2005c ). In 2009, 3 years after 
initiation of the program, 4.2 million A1C test results for almost 1.8 million indi-
viduals were registered with the NCY DOHMH (Chamany et al.  2009 ). 
2.4.3  Discussion 
 The mandated reporting of A1C results in New York City and the interventions that 
followed stimulated discussion about the role of  government in preventing  noncom-
municable diseases . Mandated communicable disease reporting is a longstanding 
and widely accepted essential public health practice, but the modern technology 
available to collect, analyze, and respond to health data today is unprecedented. 
While there are clear  population interests in controlling the sequelae of  diabetes —
preventing limb amputations and reducing care disparities, for example—there are 
also individual interests such as  privacy and  self-determination at stake. Current 
public health  ethics frameworks must consider the tension between individual and 
population interests in conjunction with the social, epidemiologic, technologic, and 
economic context of the case. 
 Proponents of the  A1C Registry argued that outreach for  noncommunicable dis-
ease is an integral part of public health practice and indeed is an  obligation of public 
health agencies, especially for a disease deemed epidemic (WHO  2011 ). They 
argued that the  A1C Registry allowed practitioners to identify patients in greatest 
need of follow-up or referral—often patients with fewest resources—and develop 
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disease management strategies (Chamany et al.  2009 ). One of the program’s goals 
in mailing test results to patients was to enable them to better manage their own 
 diabetes (e.g., only 10 % of people with diabetes know their own A1C level) (Berger 
and Silver  2008 ). 
 Others criticized some of New York City  Mayor  Michael Bloomberg’s  public 
health policies and interventions as creating a “ nanny state ” (characterized by being 
overly controlling of the lives of its citizens) (Magnusson  2014 ). Some patients 
believed that the  A1C Registry represented an unwarranted invasion of  privacy 
(Barnes et al.  2007 ), and some providers considered it an intrusion in the provider–
patient relationship (Goldman et al.  2008 ). Many who argued against public  health 
interventions such as the A1C Registry view choices about food and health—even 
when damaging—as choices that should enjoy a high degree of  autonomy uninfl u-
enced by  government (although they generally are silent about the infl uence of food 
and beverage industry  advertising ). A public health entity with fi scal and moral 
interests in the well-being of its citizenry should also work to ensure that individuals 
have accurate and actionable  information with which to make their health decisions 
(Thaler and Sunstein  2008 ). 
 Unlike the early 1900s when  Jacobson was decided, or the 1940s when the U.S. 
PHS STD  research was conducted in  Alabama and Guatemala, we now have several 
public health  ethics frameworks that help us approach ethical issues more system-
atically (Kass  2001 ; Childress et al.  2002 ; Baum et al.  2007 ; Bernheim et al.  2007 ). 
These frameworks refl ect attempts to reconcile individual and  population interests 
outlined by the  Jacobson Court. For example, the  A1C Registry case raised issues 
relating to  principles of  least infringement ,  social justice ,  health equity , and evi-
dence of benefi t. 
 When applying these ethical precepts to the  A1C Registry case, the  principle of 
 least infringement requires that public health pursue the least intrusive course of 
action that still achieves the public health goals. The A1C Registry attempted to 
accommodate this principle by allowing people to opt  out , which prevented NCY 
DOHMH from contacting patients and their clinicians, but did not relieve the labora-
tory from submitting reports to the registry. While the opt- out mechanism gives indi-
viduals some control over how their data are used, it can still allow a public health 
entity to seek to improve constituents’ well-being with minimal infringement. 
 Policy makers must also explain the aims of the program and whether benefi ts 
and burdens are expected to be distributed equitably throughout the population. In 
the  A1C Registry case, these foundational  values of  social justice and  health equity 
in large part motivated the reporting system. In New York City, substantial differ-
ences in morbidity and mortality by race/ethnicity and neighborhood income level 
were evident. NCY DOHMH use of the data to identify and then reduce these dif-
ferences promoted public health goals. One challenge in addressing such disparities 
is to ensure efforts do not inadvertently increase disparities or cause other social 
 harms , including stigma or loss of social capital. 
 Finally, policy makers have a  duty to ensure public health programs are effective, 
including empirically evaluating programs to provide evidence of this  effectiveness . 
In developing the  A1C Registry , policy makers compiled evidence from effective 
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public health programs to help explain the need and potential effectiveness of this 
program. As the NCY DOHMH evaluates the program and collects evidence of the 
A1C Registry’s effect on  diabetes in the city, it might alter  policies and procedures. 
Empirical data on the effectiveness of the registry are pending, and those results will 
certainly play an important role in assessing the program’s scientifi c and ethical 
rationale. As this brief analysis demonstrates, contemporary frameworks to guide 
ethical public health decision making offer additional nuance to the foundational 
tension between individual and  population interests. 
 The case of the A1C Registry draws attention to important implications of the 
 Jacobson  precedent and the continued infl uence of major historic breaches of public 
health ethics. The current agreed-upon equilibrium in the  United States emphasizes 
 individualism , even as similar  noncommunicable disease public health campaigns 
continue to be established (e.g., attempting to control the addition of trans fats to 
foods and the size of sugar-sweetened beverages) (Gostin  2013 ). These contempo-
rary cases in the United States are being established and deliberated in a climate of 
changing health care  policy and in the absence of an agreed-upon framework for 
public health ethics. The challenges they elucidate, however, are likely to have an 
important impact on the future role of public health in health care. 
2.5  Conclusions and Implications 
 The cases discussed here demonstrate how providing  essential public health ser-
vices requires ethical  principles and analysis as varied as the goals they hope to 
achieve. Clinical and  research ethics play a role, but are not suffi cient for the con-
sideration of competing public health  values . More substantial limits on  liberty and 
 privacy can be justifi ed as public health ethics aims to alleviate the “collective haz-
ard,” as opposed to individual  risk , for both motivation and validation of interven-
tions (Bayer and Fairchild  2004 ). However, as the cases in  Alabama and Guatemala 
underscore, limitations on  power are as important as justifi cations. 
 In different ways, the cases outlined here shaped public health practices and ethi-
cal expectations in the  United States . However, as our world grows more connected 
and our work increasingly crosses jurisdictional boundaries, it is clear that there are 
common values that motivate public health ethics even in vastly different  political , 
social, and economic contexts. The global setting in which many public health  pro-
fessionals work requires attention to such contextual factors. 
 Many of the cases outlined in the chapters that follow uncover additional ethical 
considerations affecting daily public health practice wherever that practice occurs. 
Whether it is social  duty or  political feasibility of the negative right to noninterfer-
ence, case studies can clarify ethical dimensions, help us examine alternatives for 
approaching decisions, and remind us that ethical decision making in public health 
is not an optional endeavor in  any case. These case studies underscore the need to 
identify decision-making frameworks that lead to careful consideration of individ-
ual and public interests, as a disregard for one or the other is perilous to both. 
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